Dovetail Genomics launches epigenetics society

By The Science Advisory Board staff writers

November 10, 2021 -- Dovetail Genomics has formed what it is calling the Boston Epigenetics Society, a group that will meet four times annually to support epigenetics and epitranscriptomics research and forge relationships between academics and scientists.

The society's first meeting will be held virtually on November 16 from 10-11 a.m. Eastern time. It will feature David Sinclair, PhD, professor of genetics and co-director of the Paul F. Glenn Center for Biology of Aging Research at Harvard Medical School in Boston and Robert Copeland, president, CEO, and co-founder of Accent Therapeutics.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.